喉咽反流性疾病的临床治疗研究

doi:10.6040/j.issn.1673-3770.0.2015.433

山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (1): 67-69.doi: 10.6040/j.issn.1673-3770.0.2015.433

喉咽反流性疾病的临床治疗研究

陈寻¹,杨云²,陈智斌¹

1. 南京医科大学, 江苏南京 210029;
2. 江苏盛泽医院耳鼻咽喉头颈外科, 江苏苏州 215228

收稿日期:2015-10-19 出版日期:2016-02-16 发布日期:2016-02-16
通讯作者: 陈智斌. E-mail:czbnj@163.com E-mail:chenxun911@163.co
作者简介:陈寻. E-mail:chenxun911@163.co

Research on diagnosis and treatment of laryngopharyngeal reflux disease.

CHEN Xun¹, YANG Yun², CHEN Zhibin¹

1. Nanjing Medical University, Nanjing 210029, Jiangsu, China;2. Department of Otolaryngology &Head Neck Surgery, Jiangsu Shengze Hospital, Suzhou 215228, Jiangsu, China

Received:2015-10-19 Online:2016-02-16 Published:2016-02-16

摘要/Abstract

摘要： 目的探讨喉咽反流性疾病(LPRD)的诊疗方法,同时观察LPRD患者幽门螺杆菌检出率。方法 156例反流症状指数(RSI)>13分和/或反流体征指数(RFS)>7分临床确诊为LPRD的患者,进行¹³C-尿素呼气试验(¹³C-UBT)^［4］检测,检出Hp阳性患者(I组)进行2周的幽门螺杆菌四联疗法^［5］(奥美拉唑+枸橼酸铋钾+阿莫西林+克林霉素)+甘桔冰梅片治疗后停药4周,观察Hp转阴率及LPRD转阴率;将Hp阴性患者随机分为2组,II组30例单纯给予甘桔冰梅片治疗4周后观察LPRD转阴率,III组30例给予奥美拉唑+莫沙必利+甘桔冰梅片治疗4周后观察LPRD转阴率。结果 Hp阳性检出率为61.54%(96/156),经治疗2周后停药,4周复查Hp转阴率为78.12%(75/96),I组治疗后LPRD转阴率为67.71%(65/96),II组转阴率为53.33%(16/30),III组转阴率为96.67%(29/30)。经治疗后,三组RSI和RFS评分均较治疗前降低,差异有统计学意义(t=6.73,P<0.001)。治疗后III组与II组比较,III组的RSI和RFS评分更低。结论喉咽反流是导致咽喉炎的重要病因,使用抑酸剂及消化道促动力剂可明显改善喉咽反流的症状及体征。

关键词: 幽门螺杆菌, 喉咽反流性疾病, 13碳尿素呼气试验, 幽门螺杆菌四联疗法

Abstract: Objective To discuss the diagnosis and treatment method of laryngopharyngeal reflux disease(LPRD), and to observe the detection rate of helicobacter pylori from the patients with LPRD. Methods A Total of 156 LPRD patients with reflux symptom index(RSI)over 13 and/or reflux symptom index(RFS)>7 were supplied with ¹³C-Urea Breath Test(¹³C-UBT). The Hp positive patients(n=96, group I)were administrated with quadruple therapy(Omeprazole+Bismuth Potassium Citrate+Amoxicillin+Clindamycin)and Ganju Bingmei tablets for 2 weeks, followed up with a 4 weeks of withdrawal period. The primary ourcome observed was of Hp negative transformation rate and curative effect evaluation before and after the treatment; Hp negative patients were divided into group II and group III, with 30 cases in each group. The group II was given Ganju Bingmei tablets for 4 weeks and the group III was administrated with Omeprazole+Bismuth Potassium Citrate and Ganju Bingmei Tablets for 4 weeks. The main outcome was LPRD and HP negative-converting rate. Results The Hp negative-converting rate was 78.12%(75/96)in group I. The LPRD negative-converting rate in group I, group II and group III was 67.71%(65/96), 53.33%(16/30)and 96.67%(29/30), respectively.The score of RSI and RFS were decreased in all three groups after treatment, and dropped more significantly in group III(Statistic:6.73,P<0.001). Conclusion Laryngopharyngeal reflux, as an important cause of sphagitis, can be improved by using antiacid and gastrointestinal prokinetic agents.

Key words: Helicobacter pylori, Helicobacter pylori quadruple therapy, Laryngopharyngeal reflux disease, ¹³C-Urea Breath Test

中图分类号:

R766

陈寻,杨云,陈智斌. 喉咽反流性疾病的临床治疗研究[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 67-69.

CHEN Xun, YANG Yun, CHEN Zhibin. Research on diagnosis and treatment of laryngopharyngeal reflux disease.[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 67-69.

参考文献

[1] 华杜鹃, 屈季宁, 周涛. 反流症状指数量表和反流体征指数量表在喉咽反流性疾病诊断中的应用研究[J]. 中国耳鼻咽喉头颈外科, 2013, 20(3):144-146. HUA Dujuan, QU Jining, ZHOU Tao. Application of reflux symptom index and reflux finding score in the diagnosis of laryngopharyngeal reflux disease[J]. Chin Arch Otolaryngol Head Neck Surg, 2013, 20(3):144-146.
[2] Belafsky P C, Postma G N, Koufman J A. The validity and reliability of the reflux symptom index(RSI)[J]. J Voice, 2002, 16(2):274-277.
[3] Belafsky P C, Postma G N, Koufman J A. The validity and reliability of the reflux finding score(RFS)[J]. Laryngoscope, 2001, 111(8):1313-1317.
[4] Belafsky P C, Postma G N, Amin M R, et al. Symptoms and findings of larygopharyngeal reflux[J]. Ear Nose Throat J, 2002, 81(9 Suppl 2):10-13.
[5] 汪浩, 邹文静. 胃幽门螺杆菌采用不同方法检测结果比较[J]. 世界华人消化杂志, 2015, 23(3):525-529. WANG Hao, ZOU Wenjing. Comparison of different methods for detecting Helicobacter pylori[J]. World Chin J Digestol, 2015, 23(3):525-529.
[6] 刘文忠, 谢勇,成红, 等.第四次全国幽门螺杆菌感染处理共识报告[J]. 胃肠病学, 2012, 17(10):618-623. LIU Wenzhong, XIE Yong, CHENG Hong, et al. The 4th Chinese national consensus report on management of helicobacter pylori infection[J]. Chin J Gastroenterol, 2012, 17(10): 618-623.
[7] 李燕, 郑宏良, 陈斌, 等. 甘桔冰梅片在咽喉反流性疾病治疗中的应用研究[J]. 世界中医药, 2015, 10(1):49-52. LI Yan, ZHENG Hongliang, CHEN Bin, et al. Applied research of ganju bingmei tablets the treatment of laryngopharyngeal reflux[J]. World Chin Med, 2015, 10(1):49-52.
[8] 韩德民. 重视喉咽反流在耳鼻咽喉头颈外科中的作用[J]. 中国医学文摘·耳鼻咽喉科学, 2010, 25(5):234-236. HAN Demin. Effect of Iaryrlgopharyngeal refIux in Department of ENT & HN Surgery[J]. New Reviews, 2010, 25(5):234-236.
[9] Park K H, Choi S M, Kwon S U, et al. Diagnosis of laryngopharyngeal reflux among globus patients[J]. Otolaryngol Head Neck Surg, 2006, 134(1):81-85.
[10] Kotby M N, Hassan O, El-Makhzangy A M, et al. Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature[J]. Eur Arch Otorhinolaryngol, 2010, 267(2):171-179.
[11] 李进让, 彭莉莉. 喉咽反流性疾病与胃食管反流性疾病[J]. 中国医学文摘·耳鼻咽喉科学, 2010, 25(5):256-258. LI Jinrang, PENG Lili. Laryngopharyngeal and gastroesophageal reflux diseases[J]. New Reviews, 2010, 25(5):256-258.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed

喉咽反流性疾病的临床治疗研究

Research on diagnosis and treatment of laryngopharyngeal reflux disease.

PDF (PC)

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

多维度评价

本文评价

推荐阅读 0